Annual report pursuant to Section 13 and 15(d)

Note 12 - Commitments and Contingencies (Details Textual)

v3.22.1
Note 12 - Commitments and Contingencies (Details Textual) - USD ($)
1 Months Ended 12 Months Ended
Dec. 09, 2021
Nov. 21, 2021
May 27, 2021
Mar. 16, 2021
Nov. 27, 2019
Aug. 14, 2018
Apr. 09, 2018
Nov. 02, 2017
Mar. 03, 2017
Nov. 30, 2018
Apr. 30, 2018
Jun. 30, 2016
Dec. 31, 2021
Sep. 30, 2021
Dec. 31, 2020
Dec. 31, 2019
Aug. 31, 2018
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance                         $ 624,743 $ 4,100,000 $ 2,046,907 $ (880,989)  
Common Stock [Member]                                  
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Ending Balance                         $ 221,277   $ 218,146 $ 210,232  
Former Chief Executive Officer and President [Member]                                  
Common Stock Shares Provided by Agreement (in shares)                                 1,175,000
Common Stock Shares Provided by Agreement, Escrow Period (Month)           18 months                      
Former Chief Executive Officer and President [Member] | Common Stock [Member]                                  
Stock Issued During Period, Shares, New Issues (in shares)                   925,000              
Stock Issued During Period, Shares, New Issues Placed in Escrow (in shares)                   250,000     250,000        
Former Chief Executive Officer and President [Member] | MT [Member] | Common Stock [Member] | Dr. Michael Goldberg [Member]                                  
Ownership Percentage           5.00%                      
CRG [Member]                                  
Draws on Letter of Credit             $ 7,100,000                    
CRG Loan Agreement, Texas Case [Member]                                  
Litigation Settlement, Attorneys’ Fees   $ 2,800,000                              
CRG Loan Agreement, Texas Case [Member] | Judicial Ruling [Member]                                  
Loss Contingency, Damages Awarded, Value, Additional Amount                 $ 7,000,000.0                
Loss Contingency, Damages Awarded, Value, Amount not Taken into Consideration                       $ 4,100,000          
Ohio Court of Common Pleas [Member]                                  
Litigation Settlement, Amount Awarded from Other Party         $ 4,300,000                        
Litigation Settlement, Reversal of Amount Awarded from Other Party       $ 4,300,000                          
Platinum-Montaur Life Sciences LLC Litigation [Member] | Pending Litigation [Member]                                  
Loss Contingency, Damages Sought, Value               $ 1,900,000                  
New York Litigation Involving Former CEO and President [Member] | Judicial Ruling [Member]                                  
Litigation Settlement, Amount Can Be Awarded to Other Party for Indemnification for Attorneys’ Fees     $ 14,955                            
Litigation Settlement, Amount Can Be Advanced to Other Party for Attorneys’ Fees Subject to Repayment     $ 1,237.50                            
Delaware Litigation Involving Former CEO and President [Member]                                  
Litigation Settlement, Amount Awarded from Other Party $ 66,796.33                                
CRG [Member] | Term Loan Agreement [Member] | CRG Loan Agreement, Texas Case [Member]                                  
Overpayment of Debt                     $ 4,200,000            
CRG [Member] | Term Loan Agreement [Member] | CRG Loan Agreement, Texas Case [Member] | Judicial Ruling [Member]                                  
Repayments of Debt                 59,000,000.0                
CRG [Member] | Term Loan Agreement [Member] | Maximum [Member]                                  
Debt Instrument, Agreed-upon Final Payoff Amount                 $ 66,000,000.0